ArabFinance: GlaxoSmithKline (GSK – Egypt) (BIOC) reports a consolidated net profit before minority interest of EGP 20.64 million in the first half (H1) of 2021, compared to EGP 115.95 million in the year-ago period, according to the company’s financial statements filed to the Egyptian Exchange (EGX).

Meanwhile, standalone net profit after tax dropped to EGP 39.18 million in H1 2021 from EGP 110.59 million in the prior-year period.

GSK Egypt, a member of the British pharmaceutical company Glaxo Group, is an Egypt-based company engaged in the manufacture, packaging, marketing, sale, and distribution of pharmaceutical products.